Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 96 Rectal Neoplasms 45 Colorectal Neoplasms 45 Carcinoma, Non-Small-Cell Lung 31 Esophageal Neoplasms 28 Esophageal Squamous Cell Carcinoma 24 Stomach Neoplasms 22 Lung Neoplasms 20 Pancreatic Neoplasms 19 Squamous Cell Carcinoma of Head and Neck 18 Colonic Neoplasms 18 Sarcoma 16 Neoplasms 16 Adenocarcinoma Of Esophagus 15 Ovarian Neoplasms 14 Neoplasm Metastasis 14 Head and Neck Neoplasms 14 Carcinoma, Hepatocellular 14 Prostatic Neoplasms 13 Urinary Bladder Neoplasms 12 Uterine Cervical Neoplasms 10 Inflammatory Breast Neoplasms 9 Fallopian Tube Neoplasms 9 Osteosarcoma 8 Central Nervous System Neoplasms 8 Carcinoma, Intraductal, Noninfiltrating 8 Kidney Neoplasms 7 Carcinoma, Ovarian Epithelial 7 Recurrence 6 Multiple Myeloma 6

Interventions

camrelizumab 2 spartalizumab 1 pembrolizumab 1 lenvatinib 1 apatinib 1 S 1 (combination) 1 Neoadjuvant Therapy 1 Hyperthermic Intraperitoneal Chemotherapy 1 Docetaxel 1 Albumin-Bound Paclitaxel 1 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Gastric Adenocarcinoma × Neoadjuvant Therapy × Clear all

NCT02240524 2014-09-15

HIPEC

Affiliated Cancer Hospital & Institute of Guangzhou Medical University

Phase 3 Unknown

Gastrointestinal

Advanced Gastric Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡